179 related articles for article (PubMed ID: 18651821)
1. Four patients with cutaneous metastases from medullary thyroid cancer.
Santarpia L; El-Naggar AK; Sherman SI; Hymes SR; Gagel RF; Shaw S; Sarlis NJ
Thyroid; 2008 Aug; 18(8):901-5. PubMed ID: 18651821
[TBL] [Abstract][Full Text] [Related]
2. Medullary thyroid carcinoma metastatic to skin.
Nashed C; Sakpal SV; Cherneykin S; Chamberlain RS
J Cutan Pathol; 2010 Dec; 37(12):1237-40. PubMed ID: 19615004
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous metastasis of medullary thyroid carcinoma as the initial manifestation of an otherwise limited malignancy: a case report.
Sanii S; Tavangar SM
Am J Dermatopathol; 2011 Oct; 33(7):716-8. PubMed ID: 21885943
[TBL] [Abstract][Full Text] [Related]
4. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
Paolino G; Panetta C; Didona D; Donati M; Donati P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous manifestations of thyroid cancer: a report of four cases and review of the literature.
Alwaheeb S; Ghazarian D; Boerner SL; Asa SL
J Clin Pathol; 2004 Apr; 57(4):435-8. PubMed ID: 15047753
[TBL] [Abstract][Full Text] [Related]
6. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
7. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
[TBL] [Abstract][Full Text] [Related]
8. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
9. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Elisei R; Cosci B; Romei C; Bottici V; Renzini G; Molinaro E; Agate L; Vivaldi A; Faviana P; Basolo F; Miccoli P; Berti P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2008 Mar; 93(3):682-7. PubMed ID: 18073307
[TBL] [Abstract][Full Text] [Related]
11. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
Siqueira DR; Romitti M; da Rocha AP; Ceolin L; Meotti C; Estivalet A; Puñales MK; Maia AL
Endocr Relat Cancer; 2010 Dec; 17(4):953-63. PubMed ID: 20801952
[TBL] [Abstract][Full Text] [Related]
12. Thyroid carcinoma metastatic to the skin: a cutaneous manifestation of a widely disseminated malignancy.
Dahl PR; Brodland DG; Goellner JR; Hay ID
J Am Acad Dermatol; 1997 Apr; 36(4):531-7. PubMed ID: 9092737
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous metastases from follicular thyroid cancer].
Cariou B; Charbonnel B; Heymann MF; Bridji B
Presse Med; 2000 Sep; 29(28):1557-8. PubMed ID: 11072371
[TBL] [Abstract][Full Text] [Related]
14. A nodule on the scalp as the first sign of extranodal disease in medullary thyroid carcinoma.
Ferreres-Riera JR; Vinyals-Rioseco A; Penin-Mosquera RM; Servitje-Bedate O; Marcoval-Caus J; Mascaro-Galy JM; Puig-Sarda S; Macaya-Pascual A; Fabra-Fres A
Dermatol Online J; 2017 May; 23(5):. PubMed ID: 28537865
[TBL] [Abstract][Full Text] [Related]
15. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience.
Samulski TD; Livolsi VA; Montone K; Baloch Z
Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099
[TBL] [Abstract][Full Text] [Related]
16. Role of FNA cytology and immunochemistry in the diagnosis and management of medullary thyroid carcinoma: report of six cases and review of the literature.
Bhanot P; Yang J; Schnadig VJ; Logroño R
Diagn Cytopathol; 2007 May; 35(5):285-92. PubMed ID: 17427218
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of occult medullary thyroid carcinoma at autopsy.
Valle LA; Kloos RT
J Clin Endocrinol Metab; 2011 Jan; 96(1):E109-13. PubMed ID: 20943788
[TBL] [Abstract][Full Text] [Related]
18. Nodal metastasis microRNA expression correlates with the primary tumour in MTC.
Gundara JS; Zhao JT; Gill AJ; Clifton-Bligh R; Robinson BG; Delbridge L; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):235-9. PubMed ID: 23072640
[TBL] [Abstract][Full Text] [Related]
19. Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature.
Barbosa SL; Rodien P; Leboulleux S; Niccoli-Sire P; Kraimps JL; Caron P; Archambeaud-Mouveroux F; Conte-Devolx B; Rohmer V;
Thyroid; 2005 Jun; 15(6):618-23. PubMed ID: 16029131
[TBL] [Abstract][Full Text] [Related]
20. Long-term prognosis of medullary thyroid carcinoma.
Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
